Oxford spin-out OMass Therapeutics raises €275M Series C
EU-Startups· David Cendon Garcia·· 2 days agoTop DealsAI Score74
Oxford spin-out OMass Therapeutics raises €275M Series C
Oxford spin-out OMass Therapeutics lands €275 million to bring novel small-molecule therapies closer to patients
AI Overview
OMass Therapeutics, a University of Oxford spin-out developing small-molecule drugs.
Why it matters
The round shows how European biotech investors are concentrating capital on platform-based drug discovery, with OMass's native mass spectrometry approach now funded through Phase 2.